CURRICULUM VITAE Name: Constantine Nicholas Aroney A.M., MBBS, MD, FRACP.

Associate Professor of Medicine, University of Queensland,Director of Cardiology Services, Holy Spirit Northside Hospital, Brisbane.Senior Visiting Cardiologist, Prince Charles Hospital, Brisbane.

Address: 5/166 Oxlade Drive, New Farm, Brisbane, Q'ld, 4005.Tel: 3358-6695.

Level 3, Holy Spirit Northside Hospital,Rode Rd, Chermside, 4032.Tel: 3861-5522Fax: 3861-5622Mobile: 0409-177752

Date of Birth: 18th October 1956.

Place of Birth: Brisbane, Australia.

Marital Status:Married, 4 children.

Education: 1969-1973: Church of England Grammar School, Brisbane.1979: MBBS (Q'ld) with distinctions in medicine and surgery.1985: ECFMG (USA).1986: FRACP.1987-9 : Fellow, Harvard Medical School, Boston USA1991: MD (Q'ld).2005: FCSANZ

Memberships: 1979: President, University of Queensland Medical Society.1986: Fellow, Royal Australasian College of Physicians.1987: Affiliate Member, American College of Cardiology.1987: Member, Paul Dudley White Society, Boston, USA.1989: Member, Brisbane Angioplasty Group.1990-05: Member, Cardiac Society of Australia and New Zealand. 2000: Founding Member, Asian Pacific Society of Interventional

Cardiology2005: Foundation Fellow, Cardiac Society of Australia

and New Zealand

Awards: 1976: National AMSA-AMA Award (student research grant for publ #1)

1985: National Finalist of Advanced Trainees Research Presentations

of the Royal Australian College of Physicians.1986: Cardiac Society Travel Award for Queensland to the American

Heart Association Meeting, Dallas, Texas, USA.1987-8: National Heart Foundation of Australia Overseas Clinical

Fellowship to Harvard Medical School, Boston, USA.1998: Research Grant: The Prince Charles Hospital Foundation.2000: Research Grant: The Prince Charles Hospital Foundation.2007: Member of the Order of Australia (for service to medicine in the

field of cardiology and to the Heart Foundation and Cardiac Society of Australia and NZ)

2010: Heart Foundation Honoured Contributor

Residencies:

Year Position Location

1980 Resident Royal Brisbane Hospital1981 Resident Royal Brisbane Hospital1982 Resident Royal Brisbane Hospital1983 Medical Registrar Royal Hobart Hospital1984 Cardiology Registrar Royal Hobart Hospital1985 Cardiology Registrar Royal Brisbane Hospital1986 Cardiology Registrar Prince Charles Hospital - June 1987 Cardiology Registrar Prince Charles Hospital

Fellowships:

July 1987 - July 1989:Clinical and Research Fellow, Harvard Medical School and Massachusetts General

Hospital, Boston, MA, USA.

Hospital and University Positions:

July 1989 - July 1990: Locum Cardiologist, The Prince Charles Hospital. July 1990 - February 1991: Locum Director of Cardiology, Royal Brisbane Hospital. 1991-8: Senior Lecturer, Department of Medicine, University of Qld.1991 – 2005: Senior Staff Cardiologist and Clinical Director Coronary Care Unit,

The Prince Charles Hospital, Chermside, Brisbane (half-time 2001-2005). 2000-3: PhD Supervisor, E Strodl, Uni Qld (see publication #46)2007-10: Honorary Emeritus Consultant in Cardiology, Prince Charles Hospital

Current1998- Associate Professor, Department of Medicine, University of Qld.2001- Foundation member, Qld Cardiology2001- Director, Cardiology Services, Holy Spirit Northside Hospital2010- Senior Visiting Cardiologist, Prince Charles Hospital

Medical Licence Number MED0001348683

National Committees:

1995-6: Chairman, Interventional Working Group, Cardiac Society of Australia and New Zealand.

1996-03: Member, National PTCA Database Committee, National Heart Foundation.

1996-7: Member, Quality of Care and Health Outcome Committee of the NHMRC (Management of Unstable Angina).

1996-00: Member, Relatives Values Study Committee, CSANZ.1997-00: Member, Consensus Group on Procedural Items - Relative

Value Study of the MBS.1998: Member, Cardiac Disease Working Group of the National

Health Priority Committee, Commonwealth Health Dept.1999-04: Chairman, Organizing Committee, 2004 CSANZ National

Scientific Meeting.1999-01: Chairman, Interventional Working Group, CSANZ.1999-01: Deputy Chairman, Medical Issues Committee, National Heart

Foundation of Australia.1996-2008: Member, Scientific Committee, CSANZ2001-4: Chairman, Clinical Issues Committee, National Heart

Foundation of Australia.2007-9: Member, National Prescribing Service Acute Coronary Syndrome

Reference Group2007-9: Member, Heart Foundation National Meeting 2009,

Scientific Committee2007-9: National ACS Implementation Forum (Heart Foundation)2008-9: Member Scientific Committee, Heart Foundation 50 year

Anniversary Conference2008-10: Member DMACS Project, National Prescriber Service2001-2011: Member, Clinical Issues Committee, National Heart

Foundation of Australia.1999-:2014: Co-Chairman, Writing Group, Acute Coronary Syndrome

Management Guidelines, National Heart Foundation

2014-: Editorial Board Member: Heart, Lung and Circulation

Local and State Committees:

1989 - 04 Medical advisory committee - Qld branch, National Heart Foundation.1993-95 Advisory committee of Rotary District 9600 Centre for Cardiovascular

Research, Griffith University.1994-6 Postgraduate medical education committee - PCH.1994 -04 Coronary Care Unit Management Team - PCH.

1994-02 Cardiac Rehabilitation Management Team - PCH.1994-6 Casemix Committee - PCH.1997-02 Cardiac Divisional Management Committee - PCH

Research and Ethics Committee - PCH.Cardiac Health Outcomes Reference Group (associated with Brisbane North Division of General Practice)

1990-2 Secretary, Queensland Branch, Cardiac Society of Australia and NZ.1997-2008 Chairman, Queensland Branch, Cardiac Society of Australia and NZ.2008-2010 Steering Committee – Multicentre drug use evaluation in hospitals –

Discharge management of acute coronary syndromes (DMACS) in association with the National Prescribing Service

2004-10 Qld Health Reference Group, National Heart Foundation2004-2012 Medical Advisory Committee, Holy Spirit Northside Hospital

Hospital Committees:

2001-2009 Chairman, Cardiac Services, Holy Spirit Northside Hospital.

2009- Radiation Safety Committee, Holy Spirit Northside Hospital

Publications:

1. C Mitchell, B Emmerson, C Aroney. Prevalence of respiratory morbidity in Brisbane waterside workers. Med J Aust 1981; 2:139-141. (research when a medical student)

2. CN Aroney, MR Nicholson, JE Shevland. Echocardiographic features of a mediastinal pancreatic pseudocyst. Br Heart J 1985; 53:571-573.

3. C Aroney, F Khafagi, C Boyle, N Bett. Peripartum Cardiomyopathy: Echocardiographic features in five cases. Am J Ob Gynecol 1986; 155:103-106.

4. CN Aroney, JHN Bett, D Radford. Familial idiopathic restrictive cardiomyopathy. Aust NZ J Med 1988; 18:877-78.

5. CN Aroney, TD Ruddy, RH Dighero, MA Fifer, CA Boucher, IF Palacios. Differentiation of restrictive cardiomyopathy from pericardial constriction: Assessment of diastolic function by radionuclide angiography. J Am Coll Cardiol 1989; 13:1007-14.

6. CN Aroney, HC Herrmann, MJ Semigran, GW Dec, MA Fifer. Linearity of the end-systolic pressure-volume relation in patients with severe heart failure. J Am Coll Cardiol 1989; 14:127-34.

7. CN Aroney, MJ Semigran, GW Dec, CA Boucher, MA Fifer. Inotropic effect of nicardipine in patients with heart failure: Assessment by left ventricular end-systolic pressure-volume analysis. J Am Coll Cardiol 1989; 14:1331-8.

8. MA Fifer, CN Aroney, MJ Semigran, HC Herrmann, GW Dec, CA Boucher. Techniques for assessing inotropic effects of drugs in patients with heart failure: Application to the evaluation of nicardipine. Am Heart J 1990; 119:451-6.

9. CN Aroney. Assessment of left ventricular systolic and diastolic function in patients with heart failure: methods, validation and applications. MD Thesis - University of Queensland, 1991.

10. CN Aroney, MJ Semigran, GW Dec, CA Boucher, MA Fifer. Left ventricular diastolic function in patients with left ventricular systolic dysfunction due to coronary artery disease: Effect of Nicardipine. Am J Cardiol 1991; 67:823-9.

11. MJ Semigran, CN Aroney, HC Herrmann, GW Dec, CA Boucher, MA Fifer. Effects of atrial natriuretic peptide on myocardial contractile and diastolic function in patients with heart failure. J Am Coll Cardiol 1992; 20:98-106.

12. KT McKenna, PT McEniery, F Maas, CN Aroney, JHN Bett, J Cameron, P Garrahy, G Holt, KF Hossack. Clinical results and quality of life after percutaneous transluminal coronary angioplasty: a preliminary report. Cathet Cardiovasc Diagn 1992; 27:89-94.

13. KT McKenna, PT McEniery, F Maas, CN Aroney, JHN Bett, J Cameron, G Holt, KF Hossack. Percutaneous transluminal coronary angioplasty: clinical and quality of life outcomes one year later. Aust NZ J Med 1994; 24:15-21.

14. L Carey, J Cameron, C Aroney, N Bett, G Holt, N Mahononda, P McEniery. Experience with the Gianturco-Roubin stent for abrupt vessel closure complicating percutaneous transluminal coronary angioplasty. Aust NZ J Med 1994; 24:31-5.

15. J Cameron, N Mahanonda, C Aroney, J Hayes, P McEniery, M Gardner, N Bett. Outcome five years after percutaneous transluminal coronary angioplasty or coronary artery bypass grafting for significant narrowing limited to the left anterior descending coronary artery. Am J Cardiol 1994; 74:544-549.

16. MJ Semigran, CN Aroney, HC Herrmann, GW Dec, CA Boucher, MA Fifer. Effects of atrial natriuretic peptide on left ventricular function in hypertension. Hypertension 1994; 24:271-9.

17. MA Sankardas, P McEniery, C Aroney, G Holt, J Cameron, P Garrahy, A Dare, N Bett. Directional coronary atherectomy for lesions of the proximal left anterior descending artery: Initial clinical results, complications and histopathological findings. Aust NZ J Med 1995; 25:676-80.

18. M Lynch, NV Hoffmann, CN Aroney. Thrombolytic treatment and proteinuria. British Heart Journal. 1995; 74:354-7.

19. ISIS-4 Collaborative Group. ISIS-4: A randomized factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,080 patients with suspected acute myocardial infarction. Lancet 1995; 345:669-85.

20. MA Sankardas, PT McEniery, CN Aroney, JHN Bett. Elective implantation of intracoronary stents without intravascular ultrasound guidance or subsequent warfarin. Cathet Cardiovasc Diagn. 1996; 36:355-9.

21. CN Aroney, MB Davison, EG Stafford, MF O’Brien. Internal mammary vein to coronary artery anastomotic fistula. Cathet Cardiovasc Diagn 1996; 39:407-9.

22. CK Ponde, CN Aroney, PT McEniery, JHN Bett. Plaque prolapse between the struts of the intracoronary palmaz-Schatz stent: Report of two cases with a novel treatment of this unusual problem. Cathet Cardiovasc Diagn. 1997; 40:353-7.

23. NM Caplice, CN Aroney, JHN Bett, J Cameron, JH Campbell, N Hoffmann, PT McEniery, MJ West. Growth factors released into the coronary circulation after vascular injury promotes proliferation of human vascular smooth muscle cells in culture. J Am Coll Cardiol. 1997; 29:1536-41.

24. AM Tonkin and CN Aroney. Guidelines for managing patients with unstable angina.

Rating the evidence and rationale for treatment. Med J Aust 1997; 166:644-7.

25. CN Aroney. Improving the results of coronary angioplasty. Aust NZ J Med 1997; 37:510-4.

26. CK Ponde, PS Watson, CN Aroney, M Dooris, PJ Garrahy, J Cameron, PT McEniery, JHN Bett. Multiple stent implantation in single coronary arteries: acute results and six-month angiographic follow-up. Cathet Cardiovasc Diagn 1997; 42:158-65.

27. N Dwiveedi, CN Aroney, R Slaughter. Thrombosis of a mechanical tricuspid valve prosthesis and of the left subclavian vein: Successful therapy with thrombolysis. Cath Cardiovasc Diagn 1998; 43:84-6.

28. PS Watson, CK Ponde, CN Aroney, J Cameron, A Cannon, M Dooris, PJ Garrahy, PT McEniery, JHN Bett. Angiographic follow-up and clinical experience with the flexible tantalum Cordis stent. Cathet Cardiovasc Diagn 1998; 43:168-73.

29. CN Aroney, RN Justo DJ Radford. PTCA in a 30 month old child with embolic long segment occlusion of the left anterior descending artery. Cathet Cardiovasc Diagn 1998; 44:206-9.

30. CN Aroney, JHN Bett. Transmyocardial laser revascularisation: Have we trodden this path before? (Letter) Asia Pacific Heart J 1998; 7:131.

31. PS Watson, GM Scalia, AJ Galbraith, JHN Bett, CN Aroney. Lack of effect of coenzyme Q on left ventricular function in patients with congestive heart failure. J Am Coll Cardiol 1999; 33:1549-52.

32. CN Aroney. Unstable angina: calming the troubled waters. Modern Medicine of Australia. October 1999.

33. CN Aroney. A new technique to guarantee access to the sidebranch during bifurcational coronary stenting. J Invas Cardiol 2000; 12:25-28.

34. J Cameron, C Aroney, J Bett. Left main coronary artery dissection during coronary angioplasty or angiography treated by stent insertion without requirement for emergency bypass graft surgery. Aust NZ J Med 2000; 30:726-8.

35. CN Aroney, AN Boyden, MV Jelinek, P Thompson, AM Tonkin, H White. Management of unstable angina guidelines – 2000. Med J Aust 2000; 173(supplement): S65-S88.

36. CN Aroney, AN Boyden, MV Jelinek, P Thompson, AM Tonkin, H White. Current guidelines for the management of unstable angina: a new diagnostic and management paradigm. Intern Med J: 2001; 31:104-11.

37. CN Aroney, MV Jelinek, AM Tonkin, J Vinen, H White. Management of unstable

angina. Reply. (letter) Med J Aust 2001; 174:423-4.

38. CN Aroney, P Thompson, AM Tonkin, H White. Management of unstable angina. Reply. (letter) Med J Aust 2001; 174:424-5.

39. CN Aroney. Management of the acute coronary syndromes. Australian Prescriber 2001; 24:56-9.

40. P Aylward, D Hunt, C Aroney, A. Boyden, S. Bunker, I. Cameron, J. Carapetis, G.Carroll, S. Couzos, P. Fletcher, P. French, D. Hunt, M. Loughhead, J. Parikh. Reperfusion therapy for acute myocardial infarction. Heart, Lung and Circulation 2001; 10: 99

41. GG Schwartz, AG Olsson, MD Ezekowitz et al. Effects of atorvastatin on early recurrent

ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA 2001; 285: 1711-8.

42. M Roffi, DJ Moliterno, B Meier et al. Impact of different platelet glycoprotein IIb/IIIa receptor inhibitors among diabetic patients undergoing percutaneous coronary intervention: : Do Tirofiban and ReoPro Give Similar Efficacy Outcomes Trial (TARGET) 1-year follow-up. Circulation 2002; 105: 2730-6.

43. DJ Moliterno, SJ Yakubov, PM DiBattiste et al. Outcomes at 6 months for the direct comparison of tirofiban and abciximab during percutaneous coronary revascularisation with stent placement: the TARGET follow-up study. Lancet 2002; 360: 355-60.

44. CN Aroney. Media coverage of scientific presentations (letter). Med J Aust. 2002; 177:374-5.

45. C Aroney, P Thompson. Warfarin and antiplatelet drugs (letter). Australian Prescriber 2002; 25:131.

46. E Strodl, J Kenardy, C Aroney. Perceived stress as a predictor of the self-reported new diagnosis of symptomatic CHD in older women. International Journal of Behavioural Medicine. 2003; 10:205-220.

47. AW Chan, DJ Moliterno, PB Berger et al. Triple antiplatelet therapy during percutaneous coronary intervention is associated with improved outcomes including one-year survival: results from the Do Tirofiban and ReoProGive Similar Efficacy Outcome Trial (TARGET). J Am Coll Cardiol 2003; 42: 1188-95.

48. CN Aroney, HL Dunlevie, JHN Bett. Use of an accelerated chest pain assessment protocol in patients at intermediate risk of adverse cardiac events. Med J Aust 2003; 178:370-5.

49. C Aroney, W Lapanun, G Scalia, W Parsonage. Transcatheter treatment of Lutembacher

Syndrome. Internal Med J 2003; 33:259-60.

50. DL Walters, CN Aroney, DJ Radford. Coronary stenting for a muscular bridge in a patient with hypertrophic obstructive cardiomyopathy. Cardiol Young 2003; 13:377-9.

51. J Hung, C Aroney, A Boyden, D Hunt, A Tonkin. Aspirin for cardiovascular disease prevention. Med J Aust 2003: 179:147-52.

52. J Davies, S Senes, CN Aroney, IT Meredith, L Bernstein. Nineteen year (1990-1998) review of angioplasty in Australia. Heart, Lung and Circulation 2003; A72-73.

53. CN Aroney. Myocardial infarction: Improving patient outcomes. Medicine Today - April 2004.

54. CN Aroney, TH Goh, LA Hourigan, W Dyer. Ventricular septal rupture following non-surgical septal reduction for hypertrophic cardiomyopathy: Treatment with percutaneous closure. Cathet Cardiovasc Intervention 2004; 61: 411-4.

55. JC Tardif, J Gregoire, PL Lallier et al. Effects of the acyl coenzyme A:cholesterol acyltransferase inhibitor avasimibe on human atherosclerotic lesions. Circulation 2004; 110: 3372-7.

56. I. Scott, J. Chan, C. Aroney, G. Carroll. Local thrombolysis or rapid-transfer for primay angioplasty for patients presenting with ST segment elevation myocardial infarction to hospitals without angioplasty facilities. Int Med J 2004; 34: 373-7.

57. JJ Ferguson, RM Califf, EM Antman et al. Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial. JAMA 2004; 292: 45-54.

58. C Aroney. Heart sounds made easy. (review) Heart Lung and Circulation 2004; 13: 199.

59. MJ Ray, DL Walters, N Bett, J Cameron, P Wood, C Aroney. Point-of-Care testing shows clinically relevant variation in the degree of inhibition of platelets by standard-dose abciximab therapy during percutaneous coronary intervention. Cathet Cardiovasc Intervention 2004; 62: 150-4.

60. PW Serruys, JA Ormiston, G Sianoe et al. Actinomycin-eluting stent for coronary revascularization: a randomized feasibility and safety study: the ACTION trial. J AM Coll Cardiol 2004; 44:1363-7.

61. C Aroney. Cardiac Drug Therapy: Sixth Edition. (review) Heart Lung and Circulation 2004; 13: 430.

62. MA Blazing, JA de Lemos, HD White et al. Safety and efficacy of enoxaparin vs

unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: a randomized controlled trial. JAMA 2004; 292:55-64.

63. DP Chew, RM Allan, CN Aroney, NJ Sheerin. National data elements for the clinical management of acute coronary syndromes. Med J Aust 2005; 182: S1-S16.

64. JHN Bett, AM Tonkin, PL Thompson, CN Aroney. Failure of current public educational campaigns to impact on the initial response of patients with possible heart attack. Int Med J 2005; 279-82.

65. MJ Ray, DL Walters, JHN Bett, J Cameron, P Wood, CN Aroney. Platelet-monocyte aggregates predict troponin rise after percutaneous coronary intervention and are inhibited by abciximab. Int J Cardiology 2005; 101: 249-55.

66. C Aroney. Interventional Cardiology Secrets. (review) Heart Lung and Circulation 2005; 14: 124-5.

67. C Aroney. Stable angina pectoris: Evaluation and treatment. Medicine Today. 2005; 6: 44-53.

68. S. Trivedi, CN Aroney, DL Walters, JHN Bett. Measurement of myocardial fractional flow reserve is a cost-effective way to identify coronary artery lesions of indeterminate severity that warrant revascularisation. Heart Lung and Circulation 2005; 14:239-41.

69. AP Gunasekara, DL Walters, CN Aroney. Comparison of abciximab with “high dose” tirofiban in patients undergoing percutaneous coronary intervention. Int J Cardiology 2006; 109:16-20.

70. CN Aroney, P Aylward, A-M Kelly, E Clune. Guidelines for the management of acute coronary syndromes 2006. Med J Aust 2006; 184 (Supplement):S1-S30.

71. MR Hoenig, JA Doust, CN Aroney, IA Scott. Early invasive versus conservative strategies for unstable angina & non-ST-elevation myocardial infarction in the stent era. (Cochrane Database of Systematic Reviews 2006. Jul 19;3:CD004815).

72. P Deedwania, P Barter, R Carmena et al. Reduction of low-density lipoprotein

cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targets study. Lancet 2006; 368: 919-28.

73. P Aylward, CN Aroney. Guidelines for the management of acute coronary syndromes 2006. Letter. Med J Aust 2006; 185:527.

74. CN Aroney, P Aylward. Guidelines for the management of acute coronary syndromes 2006. Letter. Med J Aust 2007; 186:101-2.

75. PJ Barter, M Caulfield, M Erikkson et al. Effects of torcetrapib in patients at high risk for coronary events. N Eng J Med. 2007; 357:2109-22.

76. A McCann, DL Walters, CN Aroney. Percutaneous balloon mitral commissurotomy in indigenous versus non-indigenous Australians. Heart Lung Circ 2008; 17:200-5.

77. DL Walters, CN Aroney, DP Chew, L Bungey, SG Coverdale, R Allen, D Brieger. Variations in the application of cardiac care in Australia. Results from a prospective audit of the treatment of patients presenting with chest pain. Med J Aust 2008; 188:218-23.

78. CN Aroney, P Aylward, DP Chew, N Huang, A-M Kelly, H White, M Wilson. 2007 addendum to the NHF/CSANZ guidelines for the management of acute coronary syndromes 2006. Med J Aust 2008; 188:302-3.

79. I Ranasinghe, D Chew, C Aroney, S Coverdale, R Allen, D Walters, D Brieger. Differences in treatment and management of indigenous and non-indigenous patients presenting with chest pain: results of the Heart Protection Partnership (HPP) study.

Heart Lung Circ 2009; 18: 32-7.

80. E Ivens, C Hamilton-Craig, C Aroney, A Clarke, H Jalali, Dj Burstow. Early and late perforation by Amplatzer atrial septal defect and patent foramen ovale devices. J Am Soc Echocardiogr 2009; 22:1067-70.

81. G Montalescot, SD Wiviott, E Braunwald et al. Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial. Lancet 2009; 373: 723-31.

82. D Brieger, A-M Kelly, C Aroney, P Tideman, SB Freedman, D Chew, M Ilton, G Carroll, I Jacobs, NP Huang. Acute coronary syndromes: consensus recommendations for translating knowledge into action. Med J Aust 2009; 191:334-9.

83. DL Bhatt, AM Lincoff, CM Gibson et al. Intravenous platelet blockade with cangrelor during PCI. N Eng J Med 2009; 361: 2230-41.

84. The Expanded Global Registry of Acute Coronary Events (GRACE2) Investigators. The expanded Global Registry of Acute Coronary Events: baseline characteristics, management practices, and hospital outcomes of patients with acute coronary syndromes. Am Heart J 2009 158:193-201.

85. Dal-OUTCOMES Committees and Investigators. Rationale and design of the dal-OUTCOMES trial: efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome. Am Heart J 2009 158:896-901.

86. DL Walters, MJ Ray, P Wood, EJ Perrin, JHN Bett, CN Aroney. High-dose tirofiban with enoxaparin and inflammatory markers in high-risk percutaneous intervention. Eur J

Clin Invest 2010; 40:139-47.

87. CN Aroney, PE Hickman, HG Schneider, JR Tate, M Than. Troponin measurement and the new assays – How low can we go? Med J Aust 2010; 192:245-6.

88. PE Hickman, JM Potter, CN Aroney, G Koerbin, E Southcott, AHB Wu, MS Roberts. Cardiac troponin may be released by ischemia alone, without necrosis. Clin Chim Acta 2010; 411:318-23.

89. D Brieger, C Aroney, D Chew, A-M Kelly, D Walters, Toohey C, Boyden A. Acute coronary syndromes: consensus recommendations for translating knowledge into action. Med J Aust 2010; 192:700-1.

90. J Layland, B Bell, J Latona, D Mullany, G Manaharan, B Thompson, C Aroney, D Walters. Novel use of a percutaneous aortic valve in stentless bioprosthetic Cryolife O’Brien valve dysfunction. J Heart Valve Dis 2010; 19:263-4.

91. C Aroney. The acute coronary syndrome. Cardiology in General Practice 2010; 11:23-5.

92. MR Hoenig, CN Aroney, IA Scott. Early invasive versus conservative strategies for unstable angina & non-ST-elevation myocardial infarction in the stent era. Cochrane Database of Systematic Reviews 2010; Mar 17; 3:CD004815.

93. DMACS Project Team. Discharge management of acute coronary syndromes project. National Prescriber Service; Dec 2010.

94. DP Chew, CN Aroney, PE Aylward, AM Kelly, HD White, PA Tideman, J Waddell, L Azadi, AJ Wilson, LM Ruta. 2011 Addendum to the National Heart Foundation of Australia/Cardiac Society of Australia and New Zealand Guidelines for the management of acute coronary syndromes (ACS) 2006. Heart Lung Circ 2011; 20:487-503.

95. CN Aroney. A suggested paradigm for coronary risk screening in asymptomatic persons – assessment of total coronary atheromatous burden. Heart Lung Circ 2012; 21: 449-54.

96. KK Poon, J Crowhurst, C James, D Campbell, D Roper, J Chan, A Incani, P Tesar, C Aroney, OC Raffel, DL Walters. Impact of optimising fluoroscopic implant angles on paravalvular regurgitation in transcatheter aortic valve replacements – utility of three dimensional rotational angiography. Eurointervention 2012; 8: 538-45.

97. DL Walters, T Boga, D Burstow, G Scalia, LA Hourigan, CN Aroney. Percutaneous ASD closure in a large Australian series – short and long term outcomes. Heart Lung Circ 2012; 21: 572-5.

98. KK Poon, A Clarke, SA Luis, P Wiemers, A Incani, G Scalia, P Tesar, OC Raffel, CN Aroney, DL Walters. First Australian trans-apical mitral valve-in-valve implant for a failed bioprosthesis. How to do it. Heart Lung Circ 2012; 21: 737-9.

99. Incani A, Butler T, Poon K, Savage M, Aroney C, Raffel C, Walters D. Investigating the relationship between CRUSADE Bleeding Score and bleeding in TAVR patients – The Prince Charles Registry. Heart Lung Circulation 2012 05 403

100. P Tricoci, Z Huang, C Held et al. Thrombin-receptor antagonist varoxapar in acute coronary syndromes (TRACER). New Eng J Med 2012; 366: 20-33.

101. DA Morrow, E Braunwald, MP Bonaca et al. Vorapaxar in the secondary prevention of atherothrombotic events. N Eng J Med 2012; 366: 1404-13.

102. GG Schwartz, AG Olsson, M Abt et al. Effects of dalcetrapib in patients with a recent acute coronary syndrome. New Eng J Med 2012; 367: 2089-99.

103. Crowhurst Jam Campbell D, Raffel C, Whitby M, Pathmanthan P, Redmond S, Incani A, Poon K, James C, Aroney C, Clarke A, Walters DL. Using Dyna CT for the assessment of iliofemoral arterial calibre, calcification and tortuosity index in patients selected for trans-catheter aortic valve replacement. Int J Cardiovasc Imaging 2013; 29: 1537-45.

104. Subban V, Incani A, Clarke A, Aroney C, Scalia G, Crowhurst J, Raffel C, Walters DL. Conservative management and resolution of a contained rupture of aortic annulus following trans-catheter valve replacement. JACC Cardiovasc Interv 2013; 6: 33-4.

105. A Clarke, P Wiemers, KK Poon, CN Aroney, G Scalia, D Burstow, DL Walters, P Tesar. Early experience in trans-aortic TAVI – The future of surgical TAVI. Heart Lung Circ 2013; 22:265-269.

106. A Murdoch, J Hunter, A Incani, O Raffel, CN Aroney, D Walters. Percutaneous aortic balloon valvuloplasty is a safe and effective bridging procedure to transcutaneous aortic valve replacement. Heart Lung Circulation 2013;

107. C Aroney. Primary prevention of cardiovascular disease: new guidelines, technologies and therapies. Med J Aust 2014; 200:146-8.

108. H Samardhi, DL Walters, C Raffel, S Rateesh, C Harley, D Burstow, P Pohlner, C Aroney. The long-term outcomes of transcoronary ablation of septal hypertrophy compared to surgical myectomy in patients with symptomatic hypertrophic obstructive cardiomyopathy. Cath Cardiovasc Interventions 2014; 83: 270-7.

109. Subban V, Savage M, Crowhurst J, Poon K, Incani A, Aroney C, Tesar P, Clarke A, Raffel C, Murdoch D, Platts D, Burstow D, Saireddy R, Bett N, Walters D. Trans-catheter vave-in-valve replacement of degenerated bioprosthetic aortic valves. A single centre Australian experience. Cardiovascular revascularisation medicine 2014; 15:388-92.

110. C Aroney. Transcutaneous aortic valve implantation – A call for action. (Lead Editorial)

Heart Lung Circ 2015; 24:216-8.

111. JA Crowhurst , M Savage,·V Subban,·A Incani,·OC Raffel, K Poon, D Murdoch, R Saireddy, A Clarke, C Aroney, N Bett, D L Walters. Factors Contributing to Acute Kidney Injury and the Impact on Mortality in Patients Undergoing Trans-catheter Aortic Valve Replacement. Heart Lung Circulation 2016; 25: 282-9.

112. V Subban, D Murdoch, ML Savage, J Crowhurst, R Saireddy, KK Poon, A Incani, N Bett, DJ Burstow, GM Scalia, A Clarke, OC Raffel, CN Aroney, DL Walters. Outcomes of transcatheter aortic valve implantation in high surgical risk and inoperable patients with aortic stenosis: a single Australian Centre experience. Int Med J. 2016; 46: 42-51.

113. C Aroney, L Cullen. Appropriate and inappropriate use of serum troponin in General Practice – A Narrative Review. Med J Aust (In Press).

Book Chapters

1. CN Aroney, JA de Lemos. Management of acute coronary syndromes. Chapter 2 Pp 15-36 in Cardiac Markers (2nd Edition, 2003), Editor AH Wu; Humana Press.

2. CN Aroney. Management of the NSTE acute coronary syndromes. Chapter 64 Pp 485-95 in Coronary Care Manual (2nd edition, 2010), Editor Peter Thompson; Elsevier Australia.

Abstracts:

1. CN Aroney, MR Nicholson, JE Shevland. 2-D echocardiographic features of cardiac compression by mediastinal pancreatic pseudocyst. Aust Soc for Ultrasound in Medicine, Adelaide, 1984.

2. CN Aroney, HE Butler, M Staley, MR Nicholson. Hypokalemia in patients receiving fixed-combination diuretics. Cardiac Soc of Aust and NZ, Adelaide, 1986.

3. CN Aroney, JHN Bett, J Egerton-Vernan, C Boyle, L Dryberg. The influence of IV nitroprusside, oral hydrallazine and metoprolol on infarct expansion in acute anterior transmural myocardial infarction. Asian-Pacific Congress in Cardiology, Auckland, NZ, 1987.

4. CN Aroney, JHN Bett, J Whiting, C Boyle. Identification of vegetations with echocardiography in septicaemic patients. Asian-Pacific Congress in Cardiology, Auckland, NZ, 1987.

5. CN Aroney, MA Fifer, CA Boucher. Left ventricular contractile function in mitral regurgitation: Rheumatic heart disease compared with mitral valve prolapse. Am Fed Clin Res, Washington, DC, 1988.

6. MJ Semigran, CN Aroney, HC Herrmann, GW Dec, CA Boucher, MA Fifer. Relative effects of inferior vena caval occlusion and nitroprusside infusion on left ventricular loading conditions in man. Am Fed Clin Res, Washington, DC, 1988.

7. TP Rocco, V Dilsizian, CN Aroney, HW Strauss, R Zusman, CA Boucher. Abnormal left ventricular volume response predicts exercise performance in hypertension. Am Coll Cardiol, Atlanta, Georgia, March 1988.

8. CN Aroney, MJ Semigran, GW Dec, CA Boucher, MA Fifer. Calcium channel blockade does not improve left ventricular diastolic function in patients with severe heart failure. Am Heart Assoc, Washington DC, Nov 1988.

9. CN Aroney, MJ Semigran, GW Dec, CA Boucher, MA Fifer. Negative inotropic effect of nicardipine in patients with heart failure: Demonstration by left ventricular end-systolic pressure-volume analysis. Am Coll Cardiol, Anaheim, California, March 1989.

10. MJ Semigran, CN Aroney, GW Dec, HC Herrmann, CA Boucher, MA Fifer. Lack of inotropic effect of atrial natriuretic factor in humans with heart failure: Demonstration by left-ventricular end-systolic pressure-volume analysis. Am Coll Cardiol, Anaheim, California, March 1989.

11. MJ Semigran, CN Aroney, GW Dec, HC Herrmann, CA Boucher, MA Fifer. Effect of atrial natriuretic factor on left ventricular diastolic function in humans with heart failure. Am Coll Cardiol, Anaheim, California, March 1989.

12. MJ Semigran, MA Fifer, HC Herrmann, CN Aroney, GW Dec. Coronary artery disease predicts early mortality in patients with severe heart failure treated with enoximone. Am Fed Clin Res, 1989.

13. MJ Semigran, CN Aroney, GW Dec, HC Herrmann, CA Boucher, MA Fifer. Atrial natriuretic factor is a vasodilator with no direct myocardial effect. Am Coll Cardiol, New Orleans, Louisiana, March 1990.

14. M Masterson, J Hayes, V Singh, R Pascoe, M Davison, C Aroney, A Murphy. Electrocardiographic analysis: Man versus machine. CSANZ, Hobart, May 1990.

15. M Masterson, V Singh, J Hayes, R Pascoe, C Aroney, A Murphy. Automated ECG analysis: Clinical comparison of three interpretive devices. Cardiac Soc of Aust and NZ, Hobart, May 1990.

16. CN Aroney, DJ Burstow. Percutaneous mitral valvuloplasty: Age predicts response to dilatation. Cardiac Soc of Aust and NZ, Perth, August 1991.

17. C Aroney, N Bett, J Cameron, P Garraghy, G Holt, K Hossack, A Murphy, J O'Keefe, Q'ld PTCA Group. Relationships between the characteristics of lesions, peak inflation pressure and angiographic success or local complications of coronary angioplasty. Cardiac Soc of Aust and NZ, Perth, August 1991.

18. KT McKenna, PT McEniery, CN Aroney, JHN Bett, J Cameron, G Holt, AL Murphy, F Maas. Early results and quality of life after percutaneous transluminal coronary angioplasty. Cardiac Soc of Aust and NZ, Perth, August 1991.

19. LM Carey, J Cameron, CN Aroney, JHN Bett, PJ Garrahy, GW Holt, N Mahanonda, PT McEniery. Experience with the Gianturco-Roubin stent for abrupt closure complicating percutaneous transluminal coronary angioplasty. Cardiac Soc of Aust and NZ, Melbourne, August 1992.

20. N Mahanonda, J Cameron, C Aroney, M Gardner, JHN Bett. A comparison of outcome after angioplasty or surgery for lesions of the left anterior descending coronary artery. Cardiac Soc of Aust and NZ, Melbourne, August 1992.

21. MJ Semigran, CN Aroney, GW Dec, MA Fifer. Abnormalities in diastolic function

progress over time in cardiac transplant recipients. Am Heart Assoc, New Orleans, Louisiana, 1992.

22. J Cameron, N Mahanonda, C Aroney, J Hayes, P McEniery, M Gardner, JHN Bett. Comparison of outcome of PTCA and coronary surgery for lesions of the left anterior descending coronary artery. Am College of Cardiology, Anaheim, California, 1993.

23. DB Cross, GM Scalia, CN Aroney, JJ Atherton, JHN Bett, JT Rivers, PJO Stride, GW Holt. Antianginal effects of captopril in hypertensive patients. Am College of Cardiology, Anaheim, California, 1993.

24. J Bou-Samra, DJ Burstow, RD Pascoe, CN Aroney. Percutaneous mitral valvuloplasty: Predictors of response to dilatation. Cardiac Soc of Aust and NZ, Christchurch, August, 1993.

25. DB Cross, GM Scalia, CN Aroney, JJ Atherton, JHN Bett, JT Rivers, PJO Stride, JA Karrasch, GW Holt. Antianginal effects of captopril in hypertensive patients. Cardiac Soc of Aust and NZ, Christchurch, August, 1993.

26. J Cameron, N Mahanonda, C Aroney, J Hayes, P McEniery, M Gardner, N Bett. Comparison of quality of life assessment post PTCA and CABG for lesions of the left anterior descending artery. Cardiac Soc of Aust and NZ, Christchurch, August, 1993.

27. JE Donnelly, DJ Burstow, CN Aroney, JHN Bett, J Cameron, PJ Garrahy, BR Harkness, GW Holt, AS Mullasari, PT McEniery. Cardiac Soc of Aust and NZ, Adelaide, 1994.

28. NM Caplice, C Aroney, JHN Bett, J Cameron, P McEniery, MJ West. PDGF release into the coronary circulation following coronary angioplasty in humans. Cardiac Soc of Aust and NZ, Adelaide, 1994.

29. AS Mullasari, CN Aroney, J Cameron, P Garrahy, G Holt, P McEniery, JHN Bett. Angiographic and procedural predictors of dissection after percutaneous coronary angioplasty. Cardiac Soc of Aust and NZ, Adelaide, 1994.

30. JHN Bett, J Cameron, N Mahanonda, CN Aroney, JR Hayes, MAH Gardner, P McEniery. Survival and symtom status after angioplasty or surgery for lesions of the left anterior descending coronary artery. European Congress of Cardiology, Berlin, 1994.

31. M Lynch, NV Hoffmann, CN Aroney. Thrombolytic therapy and proteinuria. American Heart Association, Dallas, 1994.

32. AS Mullasari, PT McEniery, CN Aroney, J Cameron, JHN Bett. Elective intracoronary stent implantation without ultrasound guidance or subsequent warfarin. Soc for Cardiac Angiography and Interventions, Orlando, 1995.

33. N Mahanonda, J Cameron, CN Aroney, JR Hayes, MAH Gardner, P McEniery, JHN

Bett. Outcome five years after angioplasty or surgery for lesions of the left anterior descending artery. Journal of Heart Failure. 1995; 2:1109.

34. Aroney CN. Mitral balloon valvotomy is effective in the elderly. Cardiac Soc of Aust and NZ, Canberra, 1995.

35. Caplice NM, Aroney CN, Bett JHN, Hoffmann N, West MJ. PDGF release into the coronary circulation following coronary angioplasty in humans. (Winner of the Ralph Reader Prize). Cardiac Soc of Aust and NZ, Canberra, 1995.

36. Higgins HC, McKenna KT, McEniery PT, Aroney CN, Cameron J, Garrahy P, Dooris M, Bett JHN. Return to work after percutaneous transluminal coronary angioplasty (PTCA): Preliminary Results. Cardiac Soc of Aust and NZ, Brisbane, 1996.

37. Tooth L, McKenna K, McEniery P, Aroney C, Cameron J, Hossack K, Holt G, Bett JHN. Educational and demographic factors predicting improved cardiac and risk factor knowledge after percutaneous transluminal coronary angioplasty (PTCA). Cardiac Soc of Aust and NZ, Brisbane, 1996.

38. Aroney CN. Improving the results of coronary angioplasty. The heart and blood vessels in health and disease. Lindeman Island. August 7-9, 1996.

39. GMA Scalia, PS Watson, AJ Galbraith, JHN Bett, CN Aroney. Study of CoEnzyme Q randomized for the treatment of congestive heart failure (SCORCH). Cardiac Soc of Aust and NZ, Hobart, 1997.

40. GR Wright-Smith, JHN Bett, P Carroll, P Naidoo, CN Aroney. Value of a bedside assay of Troponin T in patients with chest pain and a normal ECG. Cardiac Soc of Aust and NZ, Hobart, 1997.

41. C Chotinaiwattarakul, AD Cannon, CN Aroney, PT McEniery, PJ Garrahy, M Dooris, J Cameron, JHN Bett. Early experience with the second generation Gianturco-Roubin stent. Cardiac Soc of Aust and NZ, Hobart, 1997.

42. Aroney C, Burns C, Love K. Measures of quality and effectiveness in cardiac care. IXth Casmix Conference in Australia. Brisbane. September 7-10, 1997.

43. Aroney CN, Watson PS, Scalia GM, Galbraith AJ, Bett JHN. Study of coenzyme Q randomized for the treatment of congestive heart failure (SCORCH). Am Heart Assoc, Orlando, Florida, USA, November, 1997.

44. Payne J, Hall G, Capra S, Aroney C, Atkinson K, Hourigan A. Changing food patterns in patients with heart disease - empowering as well as enlightening. Australian Cardiac Rehabilitation Association Conference. Perth, August 1998,

45. Cleary S Adlam L, Mason C, Abbott E, Winkler J, Aroney C, Cameron J, McEniery P, Bett JHN. Examination of groin complications of transluminal coronary angioplasty patients treated with low molecular weight heparin. Cardiac Soc of Australia and NZ, Perth, 1998.

46. Higgins HC, McKenna KT, McEniery PT, Aroney CN, Cameron J, Dooris M, Garrahy P, Holt G, Bett JHN. Cardiac rehabilitation outcomes following intracoronary stenting and/or PTCA. Cardiac Soc of Australia and NZ, Perth, 1998.

47. Payne J, Hall G, Capra S, Aroney C, Atkinson K, Hourigan A. Changing food patterns in patients with heart disease - empowering as well as enlightening. Aust Cardiac Rehabititation Conference. Perth, August 1998.

48. Walters D, Radford DJ, Aroney CN,. Myocardial bridging in hypertrophic cardiomyopathy: In-stent restenosis following coronary stenting. Royal Australasian College of Physicians, Perth, May 1999.

49. Payne J, Aroney C. International Health Outcomes Conference, Canberra, July 1999.

50. Aroney CN, Bett JHN. Platelet inhibition with abciximab therapy - Preliminary results using a rapid platelet function assay. Cardiac Soc of Australia and NZ, Wellington,

August 1999.

51. Aroney CN, Tesar PT, Love K, Bett JHN. Comparison of functional health status before and after cardiac interventions in the Australia and the USA. Cardiac Soc of Australia and NZ, Wellington, August 1999.

52. Payne J, Aroney C. Pacific Partners in Nutrition Conference. Auckland, September 1999.

53. Aroney CN. Warfarin therapy need not be interrupted for coronary interventions using radial artery access. Cardiac Soc of Australia and NZ, Melbourne, August 2000.

54. Riha A, Potter J, Slaughter R, Aroney C. Troponin in Pulmonary Embolism Study. Cardiac Soc of Australia and NZ, Melbourne, August 2000.

55. Scalia G, Lange A, Burstow D, Aroney C. 3D echocardiography in ASD closure. Cardiac Soc of Australia and NZ, Melbourne, August 2000.

56. Scalia G, Lange A, Polka P, Donnelly J, Burstow D, Aroney C. Clinical utility of 3D echocardiography in the assessment of atrial septal defect anatomy for Amplatzer device closure. XXII Congress of the European Soc of Cardiology, Amsterdam, August, 2000.

57. Payne J, Hall G, Capra S, Aroney C, Atkinson K, Hourigan A. Stages of change and health locus of control in dietary behaviour change. Sixth International Congress of Behavioural Medicine, Brisbane, November, 2000.

58. Strodl E, Kenardy J, Aroney C. Chest pain in elderly women. International Conference for Behavioural Medicine, Brisbane, 2000.

59. Aroney CN, Dunlevie H, Bett JHN. Accelerated assessment of chest pain in intermediate risk patients: Reclassification using the new guidelines. Cardiac Soc of Australia and NZ, Auckland, August 2001.

60. Harris AM, Burstow DJ, Aroney CN. Transcoronary ablation of septal hypertrophy – Preliminary acute results. Cardiac Soc of Australia and NZ, Auckland, August 2001.

61. Trivedi S, Aroney CN. Same day discharge percutaneous coronary intervention. Why delay? Cardiac Soc of Australia and NZ, Auckland, August 2001.

62. Strodl E, Kenardy J, Aroney C. Psychological factors and angina. Australian Cardiac Rehabilitation Annual Scientific Meeting, Noosa, September 2001.

63. Bett JHN, Aroney C, Dunlevie H. Guidelines for management of patients presenting with chest pain and features of intermediate risk. World Congress of Cardiology, Sydney, May 2002.

64. Trivedi S, Aroney CN. Correlation between coronary angiographic anatomy and troponin I levels in patients with acute chest pain. World Congress of Cardiology, Sydney, May 2002.

65. Trivedi S, Aroney CN, Walters DL, Bett N. Measurement of myocardial fractional flow reserve using the Radi wire identifies coronary lesions warranting revascularistion. World Congress of Cardiology, Sydney, May 2002.

66. Ray MJ, Bett JHN, McEniery PT, Walters DL, Aroney CN. Point of care monitoring of platelet function after abciximab therapy is poorly correlated with flow-cytometric measurements of platelet activation. World Congress of Cardiology, Sydney, May 2002.

67. Davies J, Senes S, Aroney CN, Meredith IT, Bernstein L. Nineteen year (1980-1998) review of coronary angioplasty in Australia. World Congress of Cardiology, Sydney, May 2002.

68. Strodl E, Colquhoun D, Aroney C, Kennardy J. Autonomic nervous system arousal and the frequency of angina attacks. European Atherosclerosis Society Congress, Salzburg, 2002.

69. Strodl E, Aroney C, Colquhoun D, Kenardy J. Heart rate variability and the frequency of angina. European Atherosclerosis Society Congress, Salzburg, July 2002.

70. Strodl E, Kenardy J, Aroney C. Prediction of the new diagnosis of coronary heart disease in older women using psychosocial predictors. Stress and Anxiety Research (STAR) International Conference, Melbourne July 2002.

71. Strodl E, Kenardy J, Aroney C. Psychological factors and angina pectoris: The influence of moderators. International Congress of Applied Psychology, Singapore, July 2002

72. Strodl E, Kenardy J, Aroney C. Cognitive and Behaviour Therapy and cardiac rehabilitation. Australian Association for Cognitive and Behaviour Therapy - National Conference, Brisbane, July 2002

73. Ray M, Walters D, Bett N, McEniery P, Cameron J, Wood P, Aroney C. Point of care testing shows clinically relevant variation in the degree of inhibition of platelets by standard dose abciximab therapy during percutaneous coronary intervention. XIVth Congress of the International Society on Thrombosis and Haemostasis, Edinburgh, July 2003

74. Bett JHN, Tonkin AM, Thompson PJ, Aroney CN. Earlier treatment of heart attacks despite lack of effect of education campaigns on patient delay. Cardiac Soc of Australia and NZ, Adelaide, August 2003.

75. Bett JHN, Aroney CN, Dunlevie H. Use of a structured protocol for assessing patients with chest pain and intermediate risk of adverse events. Cardiac Soc of Australia and NZ, Adelaide, August 2003.

76. Walters DL, Aroney CN, Rahman, S, Hourigan LA, Scalia GS, Burstow DJ. Initial experience with intracardiac echocardiography in the cardiac interventional laboratory. Cardiac Soc of Australia and NZ, Adelaide, August 2003.

77. Walters DL, Ray MJ, Bett JHN, Wood P, Aroney CN. High dose Tirofiban with enoxaparin or unfractionated heparin in patients undergoing coronary stent placement reduces CD40 Ligand expression. Cardiac Soc of Australia and NZ, Brisbane, August 2004.

78. Walters DL, Aroney CN, Allan R, Breiger D, Brunker S, Coverdale S, Hare D, Rosenhain S. Quality of care of patients hospitalised with acute coronary syndromes. Cardiac Soc of Australia and NZ, Brisbane, August 2004.

79. Chen VHT, Fung PR, Carle AD, Nellet, Licastro R, Aroney CN. Cardiac risk factors and quality of life at 12 months following traditional cardiac rehabilitation – a prospective cohort controlled study. Cardiac Soc of Australia and NZ, Brisbane, August 2004.

80.. Gunasekara AP, Walters DL, Aroney CN. Comparison of abciximab with “high-dose” tirofiban in patients undergoing percutaneous coronary intervention. Cardiac Soc of Australia and NZ, Brisbane, August 2004.

81. Bett JHN, Tonkin AM, Thompson PL, Aroney CN. Experience is not always a good teacher: Patients known to have heart disease may delay seeking health for symptoms of possible heart attack. Cardiac Soc of Australia and NZ, Brisbane, August 2004.

82. Walters DL, Aroney CN, Bett JHN, Ray MJ, Wood P. A comparison of enoxaparin and unfractionated heparin in combination with tirofiban during percutaneous coronary intervention: effects on inhibition of coagulation. Cardiac Soc of Australia and NZ, Perth, August 2005.

83. Hourigan L, Aroney CN, Walters DL. Percutaneous septal occluder devices: A single centre experience of 133 devices. Cardiac Soc of Australia and NZ, Perth, August 2005.

84. Aroney CN. Metabolic syndrome, diabetes and the acute coronary syndrome. Asia Pacific Interventional Advances Conference. Newcastle, Nov-Dec 2005.

85. McCann A, Aroney C, Walters D. Percutaneous balloon mitral commissurotomy in indigenous vs non-indigenous Australians in Queensland 1990-2006. Cardiac Soc of Australia and NZ, Canberra, Aug 2006.

86. McCann A, Walters D, Aroney C. Percutaneous closure of ventricular septal defects using the Amplatzer VSD Occluder device. Cardiac Soc of Australia and NZ, Canberra, Aug 2006.

87. Walters DL, Ray ML, McCann A, Aroney CN. High bolus tirofiban achieves superior platelet inhibition to abciximab in patients undergoing coronary stenting. Cardiac Soc of Australia and NZ, Canberra, Aug 2006.

88. O’Dwyer K, Walters D, Parsonage W, Yadav R, Roberts C, Kamp M, Aroney C. Implementation of standardized suite of chest pain and acute coronary syndrome protocols and pathways. Heart Foundation Conference, Brisbane, May 2008.

89. Bissessor N, Jayasinghe R, Hourigan L, Scalia G, Burstow D, Aroney C, Walters D. Percuatneous septal occlude devices for patent foramen ovale. Cardiac Soc of Australia and NZ, Aug 2008.

90. Hamilton-Craig C, Ivens EL, Boga T, Aroney C, Walters DL, Burstow DJ. Early and late cardiac perforation by Amplatzer ASD and PFO devices. Cardiac Soc of Australia and NZ, Sydney, Aug 2009.

91. Aroney C, Devlin G, Duffy S, Laborde JC, Manoharan G, Meredith I, Muller D, Ormiston J, Pasupati S, Walters DL, Walton A. Echocardiographic outcomes at 30 days following percutaneous aortic valve replacement (PAVR) with Corevalve revalving in Australia and New Zealand. Cardiac Soc of Australia and NZ, Sydney, Aug 2009.

92. Aroney C, Devlin G, Duffy S, Laborde JC, Manoharan G, Meredith I, Muller D, Ormiston J, Pasupati S, Walters DL, Walton A. Percutaneous aortic valve replacement (PAVR) with Corevalve revalving in Australia and New Zealand – Initial experience. Cardiac Soc of Australia and NZ, Sydney, Aug 2009.

93. Clark RA, Wilkinson D, Coffee N, Eckert K, Astles P, Milligan M, Pearce G, Stewart S, van Gaans V, Turner D, Coombe D, Aroney C, Chew D, Grantham H, Macdonald P, MacIsaac A, Thompson P, Walsh W, Tonkin A. Mapping services to support a patient’s journey through evidence based care pathways after a cardiac event. Cardiac Soc of Australia and NZ, Sydney, Aug 2009.

94. Aroney C. Budgetary constraints and patient care. Challenges in Cardiology. Brisbane, April 2010.

95. Aroney C. Troponin: How low can we go? CSANZ Scientific meeting: AACB Symposium. Adelaide, August 2010.

96. Crowhurst J, Aroney C, Walters D. The use of perioperative C arm CT for the accurate placement of percutaneous aortic valves. Cardiac Soc of Australia and NZ, Adelaide, Aug 2010.

97. Kelly N, Walters D, Scalia G, Aroney C, Burstow D. Indexed left atrial volume improves following percutaneous aortic valve replacement with Corevalve bioprosthesis. Cardiac Soc of Australia and NZ, Adelaide, Aug 2010.

98. Nowakowski K, Gleeson S, Mullany D, Gough C, Aroney C, Walters D. Patient selection for percutaneous aortic valve replacement. Cardiac Soc of Australia and NZ, Adelaide, Aug 2010.

99. Samardhi H, Rateesh S, Syed F, Harley C, Aroney C, Walters D. An experience of transcoronary ablation of septal hypertrophy in hypertrophic cardiomyopathy. Cardiac Soc of Australia and NZ, Adelaide, Aug 2010.

100. Samardhi H, Rateesh S, Syed F, Harley C, Aroney C, Walters D. Comparison of transcoronary ablation of septal hypertrophy to surgical myectomy in hypertrophic cardiomyopathy. Cardiac Soc of Australia and NZ, Perth, Aug 2011.

101. Incani A, Poon K, Aroney C, Walters D. Major vascular complications and bleeding during transfemoral aortic valve replacement. Cardiac Soc of Australia and NZ, Perth, Aug 2011.

102. Crowhurst J, Campbell D, Robinson B, Poon K, Aroney C, Walters D. Aortic valve guide – automatic valve annulus profiling for TAVI. First Australian Experience. Cardiac Soc of Australia and NZ, Perth, Aug 2011.

103. Crowhurst J, Campbell D, Robinson B, Poon K, Aroney C, Walters D. Accurate assessment of the femoro-iliac arteries for TAVI using the on table Dyna CT. Cardiac Soc of Australia and NZ, Perth, Aug 2011.

104. Incani A, Poon K, Aroney C, Walters D. Transcatheter aortic valve-in-valve implantations for failed bioprosthetic heart valves at the Price Charles Hospital. Cardiac

Soc of Australia and NZ, Perth, Aug 2011.

105. Crowhurst J, Incani A, Poon K, Shaffe R, O’Keefe K, Aroney C, Walters D. Contrast use and acute kidney injury – transfemoral vs transapical approach TAVR: The Prince Charles Hospital registry data. Cardiac Soc of Australia and NZ, Brisbane, Aug 2012.

106. Incani A, Butler T, Poon K, Savage M, Aroney C, Raffel C, Walters D. Investigating the relationship between Crusade Bleeding Score and bleeding in TAVR patients – The Prince Charles Hospital Registry. Cardiac Soc of Australia and NZ, Brisbane, Aug 2012.

107. Incani A, Crowhurst J, Poon K, Savage M, Aroney C, Raffel C, Walters D. The clinical utility of Dyna CT and aortic valve guide software in TAVR – The Prince Charles Registry. Cardiac Soc of Australia and NZ, Brisbane, Aug 2012.

108. D Muller, C Aroney, P Jansz, J Passage, D Walters, E Yamen. Six month outcomes of an initial cohort of patients treated in the Australia and New Zealand Mitraclip Registry. Am Coll Cardiology 2013.

Reviewer

Heart Disease: A textbook of Cardiovascular Medicine. Braunwald. Eighth Edition 2008. (International reviewer)

Circulation.Catheter and Cardiovascular Intervention.Journal of American College of Cardiology.European Heart Journal.Heart.European Journal of Clinical Investigation.Medical Journal of Australia.Heart Lung and Circulation.Internal Medicine Journal.International Journal of Cardiology.

Invited Lectures:

1991: Invited lecture tour of Fiji:"Update in Cardiology""Heart Failure: assessment and management""Mitral valve disease: new methods in treatment"

1992: Invited Speaker on "After the Infarct", at 1st Annual Heart Week Symposium of the NHF, May 1993.

1995: Invited Speaker on "Interventional Cardiology in the Elderly", at the Annual Scientific Meeting of the Australian Society for Geriatrics, June 1995.

1997: Invited Speaker on “Percutaneous Mitral Valvotomy - Treatment of choice for mitral stenosis?” Cardiac Society of Aust and NZ, Hobart, 1997.

1997: Invited Speaker on “Management of patients with previous coronary artery bypass surgery” Royal Australasian College of Physicians, Qld Branch,

Noosa, October, 1997.

1998: Invited Speaker on “Coronary artery bypass surgery will be obsolete by the year 2000”Cardiac Society of Aust and NZ, Perth, 1998.

1999: Invited Speaker on “Treatment of Bifurcation Lesions - Coronary intervention at the crossroads” Cardiac Society of Aust and NZ, Wellington, NZ, August,

1999.2000: Invited Speaker and Live Case Proceduralist, Great Wall Congress of Cardiology,

Beijng, China 2000: Invited Speaker – Current Concepts Lecturer on “Cardiac troponins – Their role in clinical

cardiology” Australian Association of Clinical Biochemistry. June 2000 (Sydney, Melbourne and Brisbane lectures)2000: Invited Speaker on “Invasive management of the acute coronary syndrome” at the

2000 RACQ Annual Scientific Meeting, Coolum, 2000.2000: Invited speaker on “Outpatient Coronary Interventions” at the Millenium Intervention

Conference, Melbourne, 2000.2001: Invited Speaker on “The new Australian Guidelines for the Management of Unstable

Angina” at Contemporary Issues in Cardiology, Brisbane, January, 2001.2001: Invited Speaker on “The diagnosis and management of the acute coronary syndromes” at

Annual Cardiology Pfizer Cardiology Symposium, Surfers Paradise, January, 001. 2001: Invited Speaker on “Innovations in Interventional Cardiology” at Challenges in

Cardiology Brisbane, April 2001.2001: Invited Speaker on “The new chest pain evaluation strategy” at Qld Clinical Weekend,

21- 22nd July 2001.2002: Invited Speaker on “Transcoronary ablation of Septal Hypertrophy” at the Interventional

Cardiovascular Symposium, World Congress of Cardiology, Sydney, May 2002.2002: Invited Speaker on “Management of the acute coronary syndromes”, at the Cardiology

Symposium 2002, Bristol Myers Squib, Surfers Paradise.2003: Invited Speaker on “Drug eluting stents” at Challenges in Cardiology, Brisbane, June 3.2003: Invited speaker on “Clinical Practice Guidelines: Writing and Implementation”;

“Drug Eluting Stents”; “Acute coronary syndrome: diagnosis and management” and “A-Z Study” at the Cardiac Society of Aust NZ, Adelaide, Adelaide, August, 2003.

2004: Invited Speaker on “Management of the acute coronary syndrome” at the Quality and Innovation in Cardiac Care 2004, Princess Alexandra Hospital, Brisbane.

2004: Invited Speaker on “The Acute Coronary Syndrome”, “Advances in Non-Coronary Percutanous Interventions” at Tasmanian Cardiology Symposium Nov, 2004.

2004: Invited Speaker on “Fish Oils – Music for your heart”, at Controversies in Cardiology, Surfers Paradise May, 2004.

2005: Invited Speaker on “Metabolic Syndrome and Cardiovascular Disease”, at Controversies in Cardiology, Surfers Paradise May, 2005.

2005: Invited Speaker on “Metabolic Syndrome, Diabetes and the Acute Coronary Syndome”,

at the Asia Pacific Interventional Advances Conference, Newcastle December 2005.2006: Invited Speaker on “ACS Guidelines 2006” at CSANZ Annual Scientific Meeting,

Canberra2006: Invited Speaker on “Diagnostic Cutoffs for Troponin: The Clinicians Perspective” at

Cardiac Society of Aust NZ, Canberra 20062007: Keynote Speaker on “Troponin in Clinical Cardiology” at Challenges in Cardiology,

Heart Foundation/CSANZ meeting, Brisbane2007: Invited Speaker at CSANZ Annual Scientific Meeting, Christchurch NZ, on

Debate: Coronary artery disease should be revascularisedPlatelelet inhibitor therapy in interventional cardiology

2007: Invited Speaker at Qld RACP meeting, Noosa Qld, on “Medicine or Intervention for Coronary Artery Disease”.

2007: Invited Speaker: The Neil Gollan Lecture, Launceston General Hospital, Launceston, Tasmania.

2008: Invited Speaker: Challenges in Cardiology (Heart Foundation), Brisbane, on “Have we lost the battle against cardiovascular disease”.

2008: Debate: CT Angiography For and Against. Qld CSANZ Annual Seminar, July 20082009: Masterclass in Cardiology: Perth, Western Australia.2009: Redefining risk in the acute coronary syndrome. ANZET Symposium, Sydney, August 2009: Troponin from the cardiologists viewpoint. AACB 47th Annual Scientific Conference,

Brisbane 2009.2011: Masterclass in Cardiology; Sydney Australia2012: Invited Australian representative, International ACS Forum, Eur Soc Cardiology, Munich.2012: Invited Speaker at CSANZ Annual Scientific Meeting, Brisbane, Aug 2012

Guidelines for optimal antiplatelet therapy in ACS and PCI. Which drug, when and for how long. PCI is the best treatment for STEMI.

2012: Invited Live Case Proceduralist, ANZET Annual Scientific meeting, 2012.

ACCEL Interviews: (American College of Cardiology Extended Learning - audiotape series)September 1997: Balloon valvuloplasty – C Aroney.December 1998: Coronary bypass surgery will be obsolete in the new millennium – C Aroney.

Research in Progress:

REDUCE-IT Study Investigator/collaboratorODYSSEY Study Investigator/collaborator.Pfizer Studies on PCSK9 inhibitors

Previous Mulitcentre Studies

PEGASUS TrialMIRACL Trial Investigator/collaborator.

TARGET Study Investigator/collaborator.A-Plus study Investigator/collaborator.TNT study Investigator/collaborator.A-Z study Investigator/collaborator.Action study Investigator/collaborator.OnTarget study Investigator/collaborator.TRANSCEND Investigator/collaborator.ASSENT -4 study Investigator/collaborator.OASIS-5 study. Investigator/collaborator.SYNERGY trial. Investigator/collaborator.ILLUMINATE trial Investigator/collaborator.TRITON-TIMI 38 Investigator/collaborator.CHAMPION trial Investigator/collaborator.TRACER study Investigator/collaboratorTRA2P-TIMI 50 Investigator/collaborator.VISTA 16 trial Investigator/collaborator.Dal-Acute study Investigator/collaborator.Dal-Outcomes study Investigator/collaborator.REDUCE-IT Study Investigator/collaborator.PEGASUS Study Investigator/collaborator.ODYSSEY Study Investigator/collaborator.MODIFY Study Investigator/collaborator.GLAGOV Study Investigator/collaborator.

Registries

RUBY registry Balloon guidewire protection in ACSEndeavour registry Drug eluting Stent registryCYPHANZ registry Cypher stent registryGRACE2 registry ACS registryMedtronic Aust/NZ Corevalve registryREPRISE registry Lotus TAVI implantsSpecial Interests:

Interventional Cardiology:Coronary angioplasty and stent implantation.Percutaneous mitral balloon valvuloplasty.Percutaneous aortic valve implantation.Mitral Clip implantation.Percutaneous ASD & PFO closure.Trans-Coronary Septal Ablation for Hypertrophic Cardiomyopathy.

Acute coronary syndromes: Guidelines author.Clinical Practice Guidelines in Cardiology.Assessment of left ventricular systolic and diastolic function.Screening for coronary artery disease.

Quality Activities

1986: Biostatistics Course - 10 week course at QUT 1991-2004: Convenor of weekly Cardiology Journal Club at The Prince Charles Hospital

for medical staff and students. Regular nursing educational rounds in CCU at PCH

1991: NHMRC Clinical Trials Course - Clinical Trials Centre, Sydney.1991-2003: Tutor/Trial Examiner for FRACP Advanced Trainees.1991-2003: Convenor of Cardiac Journal Club - PCH1991-2002: Convenor of CCU Weekly Clinical Conference - PCH1995: Health Outcomes and the SF36 - Seminar, Canberra.1996: Course Director and Convenor of Trans-Australian Interventional Coronary Symposium.

Brisbane Sheraton Hotel - August 1996.1996: Workshop on teaching clinical skills in the new Graduate Medical Course.

16/10/96 - Mater Hospital.1996-9: Health outcomes study following PTCA and CABG, Prince Charles Hospital.1998-2004: Steering committee member and chairman (2000): Current and future management

of unstable coronary syndromes symposia.1999-2004: National steering committee member, Aggrastat in unstable angina.

Course Director and Convenor of Trans-Radial Intervention Workshop.November, 1999, Prince Charles Hospital.–2001: Cardiac Health Outcomes Reference Group (associated with Brisbane North Division

of General Practice) – development of guidelines for risk reduction post MI.1999: Member steering committee and principal author for developing Australian guidelines for the management of unstable angina (sponsored by NHF and CSANZ).: National steering committee, Abciximab in clinical practice.

2003: Steering committee chairman, Controversies in Cardiology, Inaugural Meeting, Gold Coast June 2003.

2001-3: PhD Supervisor for Esben Strodl, University of Qld.2003: Review of National Heart Foundation and Prince Charles Hospital Foundation Cardiovascular Research Centre (with S Harrap, R Cross, D Kavanagh, T Marwick, D Radford, A Tonkin)2004: Convenor, Annual Scientific Meeting, CSANZ, Brisbane 2004.2004-8 Steering Committee Member, Sanofi Vascular Event, Sydney .2004-8 Steering Committee Chairman, Controversies in Cardiology, Surfers Paradise.2001-8 Chairman of morbidity and mortality audit, Holy Spirit Northside Hospital.

Teaching

1985 Co-ordinator of teaching sessions in cardiology for FRACP trainees at RBH.1986 Cardiology tutor for FRACP and psychiatry trainees, at PCH.1987-9 Cardiology tutor for Harvard University medical students, at Massachusetts General

Hospital. Coronary care teaching sessions for residents and interns in Phillips House CCU, Massachusetts General Hospital.

1989 Co-ordinator of formal teaching sessions in cardiology for FRACP trainees at the Mater Hospital.

Co-ordinator cardiac journal club at PCH.Lectures at cardiac conference PCH: assessment of left ventricular systolic function

assessment of left ventricular diastolic function percutaneous balloon valvuloplasty in adultsLectures at grand rounds Mater Hospital: management of coronary artery disease assessment of left ventricular function

1990 Co-ordinator weekly formal teaching sessions in cardiology for FRACP trainees at Royal Brisbane Hospital.

1995: Lectures at cardiac conference PCH: balloon valvotomy - an update.1996 Lectures at cardiac conference PCH: problems in interventional cardiology.1997 Lectures at cardiac conference PCH: the open artery hypothesis.

Lecture at Grand Rounds PCH: Mitral Balloon Valvotomy.2002: Lecture at Grand Rounds PCH: Management of unstable angina.2010: Lecture at Grand Rounds PCH: Assessing the asymptomatic patient for coronary artery disease.

1991-2002: Co-ordinator weekly educational CCU rounds at The Prince Charles Hospitalfor medical staff and students.

Regular lecture on "Interventional Cardiology" to Coronary Care Module at PCH.Regular lecture on "Guidelines for managing NTEACS" for FRACP trainees at RACP Herston

Tutorials for Qld University medical students1991-7: Clinical skills sessions in cardiology for Year 4-5 students

2 hour tutorial sessions. Clinical attachments for Year 6 students

1997: Clinical Immersion for Year 1 student GMC October 19971998: Clinical tutor for Year 2 Graduate Medical Course

Lecture on Cardiac Failure and arrhythmiasMD405,406 - Introduction to medicine - Postgraduate diploma in

clinical pharmacy - Royal Brisbane Hospital - May 1998

1999: Clinical tutor for Year 2 Graduate Medical Course 2000-4 : Clinical tutor for Year 1-4 Graduate Medical Course 1997-2013: Preceptor, Graduate School of Medicine, UQ2009-2013: Preceptor. Griffith University School of Medicine